A macrophage-targeted platform for extending drug dosing with polymer prodrugs for pulmonary infection prophylaxis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A macrophage-targeted platform for extending drug dosing with polymer prodrugs for pulmonary infection prophylaxis
Authors
Keywords
Global health, Melioidosis, Ciprofloxacin, Drug conjugate, Prodrug, Controlled release, Alveolar macrophage, Pulmonary infection, Polymer drug conjugate
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 330, Issue -, Pages 284-292
Publisher
Elsevier BV
Online
2020-11-20
DOI
10.1016/j.jconrel.2020.11.031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 Vaccines: Status Report
- (2020) Fatima Amanat et al. IMMUNITY
- Exploitation of the bilosome platform technology to formulate antibiotics and enhance efficacy of melioidosis treatments
- (2019) Riccardo V. D'Elia et al. JOURNAL OF CONTROLLED RELEASE
- The global prevalence of latent tuberculosis: a systematic review and meta-analysis
- (2019) Adam Cohen et al. EUROPEAN RESPIRATORY JOURNAL
- Pulmonary non-tuberculous mycobacterial infections: current state and future management
- (2019) Kai Ling Chin et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment
- (2018) Anastasia Koch et al. CURRENT OPINION IN PHARMACOLOGY
- Current approaches to the discovery of novel inhaled medicines
- (2018) Peter Strong et al. DRUG DISCOVERY TODAY
- Pulmonary Delivery of Ceftazidime for the Treatment of Melioidosis in a Murine Model
- (2018) Sara I. Ruiz et al. MOLECULAR PHARMACEUTICS
- Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
- (2018) Jimin Zhang et al. Frontiers in Microbiology
- Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections
- (2018) Fang-Yi Su et al. JOURNAL OF CONTROLLED RELEASE
- Fully synthetic macromolecular prodrug chemotherapeutics with EGFR targeting and controlled camptothecin release kinetics
- (2018) Hanna Kern et al. Polymer Chemistry
- Glycan targeted polymeric antibiotic prodrugs for alveolar macrophage infections
- (2018) Jasmin Chen et al. BIOMATERIALS
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015
- (2017) Christopher Troeger et al. LANCET INFECTIOUS DISEASES
- Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic Peptides
- (2017) Hanna B. Kern et al. MOLECULAR PHARMACEUTICS
- Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?
- (2017) Richard W. Titball et al. VACCINE
- Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague
- (2017) Karleigh A. Hamblin et al. Frontiers in Microbiology
- Drug resistance in influenza A virus: the epidemiology and management
- (2017) Mazhar Hussain et al. Infection and Drug Resistance
- Inhaled Antibiotics for Gram-Negative Respiratory Infections
- (2016) Eric Wenzler et al. CLINICAL MICROBIOLOGY REVIEWS
- Increasing Experience With Melioidosis and Critical Care
- (2016) Graeme MacLaren et al. CRITICAL CARE MEDICINE
- Formulation and Characterization of Nanocluster Ceftazidime for the Treatment of Acute Pulmonary Melioidosis
- (2016) Sara I. Ruiz et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Chemotherapeutic copolymers prepared via the RAFT polymerization of prodrug monomers
- (2016) H. N. Son et al. Polymer Chemistry
- Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis
- (2016) Direk Limmathurotsakul et al. Nature Microbiology
- Development of Liposomal Ciprofloxacin to Treat Lung Infections
- (2016) David Cipolla et al. Pharmaceutics
- Inhaled formulations and pulmonary drug delivery systems for respiratory infections
- (2015) Qi (Tony) Zhou et al. ADVANCED DRUG DELIVERY REVIEWS
- Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors
- (2015) Majed M. Masadeh et al. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
- Melioidosis: Evolving Concepts in Epidemiology, Pathogenesis, and Treatment
- (2015) Bart Currie SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Liposome Encapsulation of Ciprofloxacin Improves Protection against Highly Virulent Francisella tularensis Strain Schu S4
- (2014) Karleigh A. Hamblin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Liposome-Encapsulated Ciprofloxacin in a Murine Model of Q Fever
- (2014) I. H. Norville et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment and prophylaxis of melioidosis
- (2014) David Dance INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial therapies for Q fever
- (2013) Gilbert J Kersh Expert Review of Anti-Infective Therapy
- Pharmacokinetic considerations for targeted drug delivery
- (2012) Fumiyoshi Yamashita et al. ADVANCED DRUG DELIVERY REVIEWS
- Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection
- (2012) Sarovich et al. Infection and Drug Resistance
- Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
- (2011) S.M. Moghimi et al. Annual Review of Pharmacology and Toxicology
- Clinical Features and Epidemiology of Melioidosis Pneumonia: Results From a 21-Year Study and Review of the Literature
- (2011) E. M. Meumann et al. CLINICAL INFECTIOUS DISEASES
- General Principles of Antimicrobial Therapy
- (2011) Surbhi Leekha et al. MAYO CLINIC PROCEEDINGS
- Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei
- (2011) N. Chantratita et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of Surrogate Animal Models of Melioidosis
- (2011) Jonathan Mark Warawa Frontiers in Microbiology
- Strategies for Intracellular Survival of Burkholderia pseudomallei
- (2011) Elizabeth M. Allwood et al. Frontiers in Microbiology
- Pathogenicity of High-Dose Enteral Inoculation of Burkholderia pseudomallei to Mice
- (2010) T. Eoin West et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Present and future therapeutic strategies for melioidosis and glanders
- (2010) D Mark Estes et al. Expert Review of Anti-Infective Therapy
- The Epidemiology and Clinical Spectrum of Melioidosis: 540 Cases from the 20 Year Darwin Prospective Study
- (2010) Bart J. Currie et al. PLoS Neglected Tropical Diseases
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now